|Awarded On||May 18, 2016|
|Title||Preclinical Candidate Discovery Core|
|Award Mechanism||Core Facility Support Awards|
|Institution/Organization||Baylor College of Medicine|
|Principal Investigator/Program Director||Martin M Matzuk|
|Cancer Sites||All Sites|
We need more rapid and less expensive strategies to discover novel anti-cancer medicines if we hope to improve patient survival and reduce treatment costs for patients with this devastating disease. The need for a larger arsenal of targeted therapeutics is particularly apparent as improved diagnostics and mutation profiling suggest new pathway-specific approaches for personalized treatment. To address the technological and economic challenges of identifying new drug candidates for cancer, we plan to use this CPRIT Core Award to develop a Preclinical Candidate Discovery Core (PCDC). The mission of the PCDC is to supply Texas cancer researchers and physicians with novel compounds to study canc...